NSG223 EXAM 1 EXAM QUESTIONS AND ANSWERS

NSG223 EXAM 1 EXAM QUESTIONS AND
ANSWERS

Save




Terms in this set (236)


Male 20-40 u/L
AST
Female 15-30 u/L

Male 19-36 u/L
ALT
Female 24-36 u/L

ALBUMIN 3.4-4.8 g/dL

BILIRUBIN < 1.2 mg/dL

BUN 8-21 mg/dL

Male 0.61-1.21 mg/dL
CREATININE
Female 0.51-1.11 mg/dL

SERUM DIGOXIN 0.5-2.0 ng/mL

SERUM CALCIUM 9-11 mg/dL

SERUM POTASSIUM 3.5-5.0 mEq/L

TOTAL CHOLESTEROL < 200 mg/dL

HDL > 60 mg/dL

LDL < 100 mg/dL

TRIGLYCERIDES < 150 mg/dL

aPTT (NORMAL) 25-30 seconds

aPTT (THERAPEUTIC) 60-80 seconds (1.5-2 x normal)

, PT (NORMAL) 11-14 seconds

PT (THERAPEUTIC) 18-24 seconds (1.5-2 x normal)

INR (NORMAL) 0.9-1.2 seconds

INR (THERAPEUTIC) 2-3 seconds

4,500-11,100 cells/microL
WBC
(4.5-11.1 x 10^3)

Male 4.21-5.81 x 10^6 cells/microL
RBC
Female 3.61-5.11 x 10^6 cells/microL

Male 14.0-17.3 g/dL
HGB
Female 11.7-15.5 g/dL

Male 42-52%
HCT
Female 36-48%

PLT 150,000-400,000/microL

Right patient, right medication, right dose, right route,
RIGHTS OF DRUG
right time, right documentation, right education, right
ADMINISTRATION
to refuse, right assessment, right evaluation.

A alright
B be careful
DRUG PREGNANCY
C controversial
CATEGORIES
D don't do it
X never

What the body does to the drug.
PHARMACOKINETICS
Absorption, distribution, metabolism and excretion.

AST/ALT/Bilirubin/Serum Albumin. Increased levels
LIVER FUNCTION TESTS
indicate hepatic function issues which would effect
(LFT's)
metabolism of medications.

BUN/Creatinine. Increased levels indicate renal
RENAL FUNCTION TESTS function issues which would effect excretion of
medications.